I-Ping Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
I-Ping Lee has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Chin-Fang Su
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
3 shared publications - Jui-Hung Kao
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan
3 shared publications - Chien-Chih Lai
Division of Allergy, Immunology, and Rheumatology, Department of Medicine Taipei Veterans General Hospital Taipei Taiwan
2 shared publications Sheng-Hong Lin
Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taipei Medical University, Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan
2 shared publications- Sheng-Hong Lin
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital Taipei Medical University New Taipei City Taiwan
2 shared publications Yu-Sheng Chang
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
2 shared publications
Latest Publications
- 29 May 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11)
Risk of osteoporotic fractures in patients with newly diagnosed pemphigus
- 29 May 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (11)
Risk of osteoporotic fractures in patients with newly diagnosed pemphigus
- Open Access
Epidemiology and risk of psychiatric disorders in patients with polymyositis and dermatomyositis: a nationwide population-based cohort study in Taiwan
Objectives To evaluate the incidence and risk factors for psychiatric disorders, including depression and anxiety, and assess the risk of suicide in patients with polymyositis (PM) and dermatomyositis (DM). Design Retrospective cohort study. Setting Data were obtained from Taiwan’s National Health Insurance Research Database (NHIRD) between 2000 and 2018. Participants A total of 3477 patients with PM/DM and 13 908 age- and sex-matched non-PM/DM controls were included in the study. Primary and secondary outcome measures The primary outcome was the incidence and risk of psychiatric disorders in patients with PM/DM compared with controls. Secondary outcomes included the identification of risk factors for psychiatric disorders, mortality and suicide risk in the PM/DM cohort. Results The incidence rate ratio (IRR) of psychiatric disorders was significantly higher in the PM/DM cohort than in controls (IRR 1.62, 95% CI 1.39 to 1.89), with depression being the most prevalent disorder (IRR 2.25, 95% CI 1.83 to 2.75). Key risk factors included female sex, intravenous steroid therapy, and high-dose oral steroid use. Additionally, the PM/DM cohort exhibited a higher mortality rate (IRR 3.4, 95% CI 3.15 to 3.67) and elevated suicide risk (IRR 1.99, 95% CI 0.96 to 3.86) compared with controls. Conclusion Patients with PM/DM face a significantly higher risk of psychiatric disorders, mortality and suicide. Integrating mental healthcare into the routine management of PM/DM is crucial to improving patient outcomes and reducing mortality. Future research should focus on the impact of early psychiatric interventions on survival outcomes in this population.
Open AccessEpidemiology and risk of psychiatric disorders in patients with polymyositis and dermatomyositis: a nationwide population-based cohort study in Taiwan
Objectives To evaluate the incidence and risk factors for psychiatric disorders, including depression and anxiety, and assess the risk of suicide in patients with polymyositis (PM) and dermatomyositis (DM). Design Retrospective cohort study. Setting Data were obtained from Taiwan’s National Health Insurance Research Database (NHIRD) between 2000 and 2018. Participants A total of 3477 patients with PM/DM and 13 908 age- and sex-matched non-PM/DM controls were included in the study. Primary and secondary outcome measures The primary outcome was the incidence and risk of psychiatric disorders in patients with PM/DM compared with controls. Secondary outcomes included the identification of risk factors for psychiatric disorders, mortality and suicide risk in the PM/DM cohort. Results The incidence rate ratio (IRR) of psychiatric disorders was significantly higher in the PM/DM cohort than in controls (IRR 1.62, 95% CI 1.39 to 1.89), with depression being the most prevalent disorder (IRR 2.25, 95% CI 1.83 to 2.75). Key risk factors included female sex, intravenous steroid therapy, and high-dose oral steroid use. Additionally, the PM/DM cohort exhibited a higher mortality rate (IRR 3.4, 95% CI 3.15 to 3.67) and elevated suicide risk (IRR 1.99, 95% CI 0.96 to 3.86) compared with controls. Conclusion Patients with PM/DM face a significantly higher risk of psychiatric disorders, mortality and suicide. Integrating mental healthcare into the routine management of PM/DM is crucial to improving patient outcomes and reducing mortality. Future research should focus on the impact of early psychiatric interventions on survival outcomes in this population.
- 24 August 2020
- Published by SAGE Publications in Lupus
- Vol. 29 (12) , 1650-1651
Severe systemic lupus erythematosus flare after abatacept treatment
- 24 August 2020
- Published by SAGE Publications in Lupus
- Vol. 29 (12) , 1650-1651
Severe systemic lupus erythematosus flare after abatacept treatment